Xeris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Updates

Go back to Xeris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Updates
(NASDAQ: XERS) Delayed: 8.20 +0.04 (0.49%)
Previous Close $8.16    52 Week High
Open $8.10    52 Week Low
Day High $8.25    P/E N/A 
Day Low $7.93    EPS
Volume 3,876,941